GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tesaro Inc (NAS:TSRO) » Definitions » PS Ratio

Tesaro (Tesaro) PS Ratio : 18.70 (As of May. 12, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Tesaro PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Tesaro's share price is $74.96. Tesaro's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 was $4.01. Hence, Tesaro's PS Ratio for today is 18.70.

The historical rank and industry rank for Tesaro's PS Ratio or its related term are showing as below:

TSRO's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 9.095
* Ranked among companies with meaningful PS Ratio only.

Tesaro's Revenue per Sharefor the three months ended in Sep. 2018 was $1.17. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 was $4.01.

Back to Basics: PS Ratio


Tesaro PS Ratio Historical Data

The historical data trend for Tesaro's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tesaro PS Ratio Chart

Tesaro Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
PS Ratio
Get a 7-Day Free Trial - - 6,540.00 140.38 20.12

Tesaro Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.32 20.12 11.49 8.13 9.73

Competitive Comparison of Tesaro's PS Ratio

For the Biotechnology subindustry, Tesaro's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tesaro's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tesaro's PS Ratio distribution charts can be found below:

* The bar in red indicates where Tesaro's PS Ratio falls into.



Tesaro PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Tesaro's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=74.96/4.009
=18.70

Tesaro's Share Price of today is $74.96.
Tesaro's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Tesaro  (NAS:TSRO) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Tesaro PS Ratio Related Terms

Thank you for viewing the detailed overview of Tesaro's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tesaro (Tesaro) Business Description

Traded in Other Exchanges
N/A
Address
Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product candidates, the company intends to pursue commercialization in key product markets, including North America, Europe, and China. Tesaro is currently focused on commercializing products directly in North America, and directly or in partnership with established companies in Europe and China. The company's strategy is to identify, acquire, and develop promising drug candidates, and to commercialize cancer therapeutics that are potentially safer and more effective than existing treatments.
Executives
Mary Lynne Hedley director, officer: President & COO C/O TESARO, INC., 1000 WINTER ST., STE 3300, WALTHAM MA 02451
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Huber Martin H. Jr. officer: SVP & Chief Medical Officer C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Moulder Leon O Jr director, officer: Chief Executive Officer C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
James O Armitage director C/O TESARO, INC., 1000 WINTER ST., SUITE 3300, WALTHAM MA 02451
Timothy R Pearson officer: Exec. VP, CFO C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Garry A Nicholson director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Grant C. Bogle officer: Sr. VP, Chief Commercial Ofc C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Nea Partners 13, Limited Partnership 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202
Nea 13 Gp, Ltd 10 percent owner 1119 ST. PAUL STREET, BALTIMORE MD 21202
New Enterprise Associates 13 Lp 10 percent owner 1119 ST PAUL STREET, BALTIMORE MD 21202
Collier Earl M Jr director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Beth C Seidenberg director
Joseph L Farmer officer: Sr VP, Gen Counsel & Secretary C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Patrick J Kerins 10 percent owner

Tesaro (Tesaro) Headlines

From GuruFocus